肋骨有症状的渐进性单鼻性纤维性形的外科治疗:一个病例报告
Anita Paiva1, Rafael Martins2, João Serra1
1Thoracic Surgery, Unidade Local de Saúde de São João, Porto, PRT.
Cureus
|February 19, 2026
概括
纤维性发育不良可能在初始治疗后的几年内进展,即使在部分切除后. 完全切除受影响肋骨的手术切除可以有效地解决选择患者的持续症状.
科学领域:
- 整形外科 整形外科 整形外科
- 骨发育不良症 骨发育不良症
- 胸部外科手术 胸部外科手术
背景情况:
- 纤维发育不良是一种良性骨疾病,正常骨被纤维组织取代,导致脆弱,变形和疼痛.
- 它通常呈现为单位性 (单个骨头) 或多位性 (多个骨头) 形式,严重程度各不相同.
- 管理通常涉及保守的方法,如监测和疼痛管理,而手术只适用于特定的症状病例.
研究的目的:
- 报告一例晚期疾病进展的肋骨纤维发育不良的病例.
- 为了评估彻底的外科切除对于持久症状的疗效.
主要方法:
- 一个33岁的男性病例报告,在第六肋骨有纤维性发育不良史.
- 对临床病史,成像 (CT扫描) 和手术结果的审查.
- 纤维发育不良症的组织病理学确认.
主要成果:
- 患者在第六肋骨的初始部分切除后15年经历了持续的胸痛.
- 脑电图扫描显示,纤维发育不良症在剩余的肋骨部分的进展.
- 对受影响的第六肋骨进行完整的外科切除导致症状完全消失.
结论:
- 纤维发育不良可能出现晚期进展,强调需要长期对患者进行随访.
- 完整的外科切除是选择的肋骨纤维发育不良症候群病例的可行和有效的治疗方法.
- 这一案例强调了考虑对耐火症状进行手术干预的重要性.
相关概念视频
Mitral Stenosis III: Medical Management
328
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
328
Inflammatory Bowel Disease V: Surgical Management
731
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
731
Cystic Fibrosis: Management
554
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
554
Esophageal Strictures-II: Clinical Features and Management
726
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
726
Urinary Tract Calculi VI: Surgical Management
616
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
616
Pleural Effusion II: Symptoms and Management
839
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
839


